Literature DB >> 16804760

Differential involvement of intracellular Ca2+ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells.

Dong Hee Lee1, Young Su Han, Eun Sook Han, Hyoweon Bang, Chung Soo Lee.   

Abstract

1-Methyl-4-phenylpyridinium (MPP(+)) or 6-hydroxydopamine (6-OHDA) caused a nuclear damage, the mitochondrial membrane permeability changes, leading to the cytochrome c release and caspase-3 activation, the formation of reactive oxygen species and the depletion of GSH in PC12 cells. Nicardipine (a calcium channel blocker), EGTA (an extracellular calcium chelator), BAPTA-AM (a cell permeable calcium chelator) and calmodulin antagonists (W-7 and calmidazolium) attenuated the MPP(+)-induced mitochondrial damage and cell death. In contrast, the compounds did not reduce the toxicity of 6-OHDA. Treatment with MPP(+ )or 6-OHDA evoked the elevation of intracellular Ca(2+) levels. Unlike cell injury, addition of nicardipine, BAPTA-AM and calmodulin antagonists prevented the elevation of intracellular Ca(2+) levels due to both toxins. The results show that the MPP(+)-induced formation of the mitochondrial permeability transition seems to be mediated by elevation of intracellular Ca(2+) levels and calmodulin action. In contrast, the 6-OHDA-induced cell death seems to be mediated by Ca(2+)-independent manner.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16804760     DOI: 10.1007/s11064-006-9088-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  42 in total

1.  Calcium/calmodulin-modulated chloride and taurine conductances in cultured rat astrocytes.

Authors:  Guangze Li; Yin Liu; James E Olson
Journal:  Brain Res       Date:  2002-01-18       Impact factor: 3.252

Review 2.  Review: The role of glutathione in the regulation of apoptosis.

Authors:  A G Hall
Journal:  Eur J Clin Invest       Date:  1999-03       Impact factor: 4.686

Review 3.  The mitochondrial death pathway and cardiac myocyte apoptosis.

Authors:  Michael T Crow; Kartik Mani; Young-Jae Nam; Richard N Kitsis
Journal:  Circ Res       Date:  2004-11-12       Impact factor: 17.367

4.  Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells.

Authors:  D H Kim; Y Y Jang; E S Han; C S Lee
Journal:  Eur J Neurosci       Date:  2001-05       Impact factor: 3.386

5.  Degeneration of pre-labelled nigral neurons induced by intrastriatal 6-hydroxydopamine in the rat: behavioural and biochemical changes and pretreatment with the calcium-entry blocker nimodipine.

Authors:  J Sautter; A Kupsch; C D Earl; W H Oertel
Journal:  Exp Brain Res       Date:  1997-10       Impact factor: 1.972

6.  Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes.

Authors:  R J van Klaveren; P H Hoet; J L Pype; M Demedts; B Nemery
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

7.  Chromaffin cell death induced by 6-hydroxydopamine is independent of mitochondrial swelling and caspase activation.

Authors:  María F Galindo; Joaquín Jordán; Carmen González-García; Valentín Ceña
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

8.  The parkinsonian neurotoxin MPP+ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism.

Authors:  D S Cassarino; J K Parks; W D Parker; J P Bennett
Journal:  Biochim Biophys Acta       Date:  1999-01-06

9.  Loading dependence of inositol 1,4,5-trisphosphate-induced Ca2+ release in the clonal cell line A7r5. Implications for the mechanism of quantal Ca2+ release.

Authors:  J B Parys; L Missiaen; H De Smedt; R Casteels
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

10.  Bcl-x L blocks mitochondrial multiple conductance channel activation and inhibits 6-OHDA-induced death in SH-SY5Y cells.

Authors:  Joaquín Jordán; María F Galindo; Daniel Tornero; Carmen González-García; Valentín Ceña
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

View more
  6 in total

1.  The homocysteine-inducible endoplasmic reticulum stress protein counteracts calcium store depletion and induction of CCAAT enhancer-binding protein homologous protein in a neurotoxin model of Parkinson disease.

Authors:  Srinivasulu Chigurupati; Zelan Wei; Cherine Belal; Myriam Vandermey; George A Kyriazis; Thiruma V Arumugam; Sic L Chan
Journal:  J Biol Chem       Date:  2009-05-15       Impact factor: 5.157

2.  Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide.

Authors:  Sarika Singh; Sachin Kumar; Madhu Dikshit
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

3.  DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.

Authors:  Xinglong Wang; Bo Su; Wanhong Liu; Xiaohua He; Yuan Gao; Rudy J Castellani; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Aging Cell       Date:  2011-06-14       Impact factor: 9.304

Review 4.  Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Authors:  Cristobal de Los Rios; Maria F Cano-Abad; Mercedes Villarroya; Manuela G López
Journal:  Pflugers Arch       Date:  2017-08-19       Impact factor: 3.657

5.  Glycyrrhizin Attenuates MPTP Neurotoxicity in Mouse and MPP-Induced Cell Death in PC12 Cells.

Authors:  Yun Jeong Kim; Chung Soo Lee
Journal:  Korean J Physiol Pharmacol       Date:  2008-04-30       Impact factor: 2.016

6.  Allopregnanolone Modulates GABAAR-Dependent CaMKIIδ3 and BDNF to Protect SH-SY5Y Cells Against 6-OHDA-Induced Damage.

Authors:  Tongtong Wang; Xin Ye; Wei Bian; Zhichi Chen; Juanjuan Du; Mengyi Li; Peng Zhou; Huairui Cui; Yu-Qiang Ding; Shuangshuang Qi; Min Liao; Chenyou Sun
Journal:  Front Cell Neurosci       Date:  2020-01-13       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.